Dataset Information

Helicobacter pylori colonization ameliorates glucose homeostasis in mice through a PPAR ?-dependent mechanism.

ABSTRACT:

Background

There is an inverse secular trend between the incidence of obesity and gastric colonization with Helicobacter pylori, a bacterium that can affect the secretion of gastric hormones that relate to energy homeostasis. H. pylori strains that carry the cag pathogenicity island (PAI) interact more intimately with gastric epithelial cells and trigger more extensive host responses than cag(-) strains. We hypothesized that gastric colonization with H. pylori strains differing in cag PAI status exert distinct effects on metabolic and inflammatory phenotypes.

Methodology/principal findings

To test this hypothesis, we examined metabolic and inflammatory markers in db/db mice and mice with diet-induced obesity experimentally infected with isogenic forms of H. pylori strain 26695: the cag PAI wild-type and its cag PAI mutant strain 99-305. H. pylori colonization decreased fasting blood glucose levels, increased levels of leptin, improved glucose tolerance, and suppressed weight gain. A response found in both wild-type and mutant H. pylori strain-infected mice included decreased white adipose tissue macrophages (ATM) and increased adipose tissue regulatory T cells (Treg) cells. Gene expression analyses demonstrated upregulation of gastric PPAR ?-responsive genes (i.e., CD36 and FABP4) in H. pylori-infected mice. The loss of PPAR ? in immune and epithelial cells in mice impaired the ability of H. pylori to favorably modulate glucose homeostasis and ATM infiltration during high fat feeding.

Conclusions/significance

Gastric infection with some commensal strains of H. pylori ameliorates glucose homeostasis in mice through a PPAR ?-dependent mechanism and modulates macrophage and Treg cell infiltration into the abdominal white adipose tissue.

SUBMITTER: Bassaganya-Riera J

PROVIDER: S-EPMC3499487 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Helicobacter pylori colonization ameliorates glucose homeostasis in mice through a PPAR γ-dependent mechanism.

Bassaganya-Riera Josep J Dominguez-Bello Maria Gloria MG Kronsteiner Barbara B Carbo Adria A Lu Pinyi P Viladomiu Monica M Pedragosa Mireia M Zhang Xiaoying X Sobral Bruno W BW Mane Shrinivasrao P SP Mohapatra Saroj K SK Horne William T WT Guri Amir J AJ Groeschl Michael M Lopez-Velasco Gabriela G Hontecillas Raquel R

PloS one 20121115 11

<h4>Background</h4>There is an inverse secular trend between the incidence of obesity and gastric colonization with Helicobacter pylori, a bacterium that can affect the secretion of gastric hormones that relate to energy homeostasis. H. pylori strains that carry the cag pathogenicity island (PAI) interact more intimately with gastric epithelial cells and trigger more extensive host responses than cag(-) strains. We hypothesized that gastric colonization with H. pylori strains differing in cag PA ...[more]

PMID: 23166823

Similar Datasets

Project description:Colonization of gastric mucosa by Helicobacter pylori leads to epithelial hyperproliferation, which increases the risk for gastric adenocarcinoma. One H pylori virulence locus associated with cancer risk, cag, encodes a secretion system that transports effectors into host cells and leads to aberrant activation of ?-catenin and p120-catenin (p120). Peroxisome proliferator-activated receptor (PPAR)? is a ligand-activated transcription factor that affects oncogenesis in conjunction with ?-catenin. We used a carcinogenic H pylori strain to define the role of microbial virulence constituents and PPAR? in regulating epithelial responses that mediate development of adenocarcinoma.Gastric epithelial cells or colonies were co-cultured with the H pylori cag(+) strain 7.13 or cagE(-), cagA(-), soluble lytic transglycosylase(-), or cagA(-)/soluble lytic transglycosylase(-) mutants. Levels of PPAR? and cyclin E1 were determined by real-time, reverse-transcription polymerase chain reaction, immunoblot analysis, or immunofluorescence microscopy; proliferation was measured in 3-dimensional culture. PPAR? and Ki67 expression were determined by immunohistochemical analysis of human biopsies and rodent gastric mucosa.H pylori induced ?-catenin- and p120-dependent expression and activation of PPAR? in gastric epithelial cells, which were mediated by the cag secretion system substrates CagA and peptidoglycan. H pylori stimulated proliferation in vitro, which required PPAR?-mediated activation of cyclin E1; H pylori did not induce expression of cyclin E1 in a genetic model of PPAR? deficiency. PPAR? expression and proliferation in rodent and human gastric tissue was selectively induced by cag(+) strains and PPAR? levels normalized after eradication of H pylori.The H pylori cag secretion system activates ?-catenin, p120, and PPAR?, which promote gastric epithelial cell proliferation via activation of cyclin E1. PPAR? might contribute to gastric adenocarcinoma development in humans.

Project description:BackgroundPersistent fibroblast activation initiated by transforming growth factor β (TGF-β) is a fundamental event in the pathogenesis of systemic sclerosis, and its pharmacological inhibition represents a potential therapeutic strategy. The nuclear receptor, peroxisome proliferator-activated receptor γ (PPAR-γ), exerts potent fibrotic activity. The synthetic oleanane triterpenoid, 2-cyano-3,12-dioxo-olean-1,9-dien-28-oic acid (CDDO), is a PPAR-γ agonist with potential effects on TGF-β signalling and dermal fibrosis.ObjectiveTo examine the modulation of fibrogenesis by CDDO in explanted fibroblasts, skin organ cultures and murine models of scleroderma.Material and methodsThe effects of CDDO on experimental fibrosis induced by bleomycin injection or by overexpression of constitutively active type I TGF-β receptor (TgfbR1ca) were evaluated. Modulation of fibrotic gene expression was examined in human skin organ cultures. To delineate the mechanisms underlying the antifibrotic effects of CDDO, explanted skin fibroblasts cultured in two-dimensional monolayers or in three-dimensional full-thickness human skin equivalents were studied.ResultsCDDO significantly ameliorated dermal fibrosis in two complementary mouse models of scleroderma, as well as in human skin organ cultures and in three-dimensional human skin equivalents. In two-dimensional monolayer cultures of explanted normal fibroblasts, CDDO abrogated fibrogenic responses induced by TGF-β. These CDDO effects occurred via disruption of Smad-dependent transcription and were associated with inhibition of Akt activation. In scleroderma fibroblasts, CDDO attenuated the elevated synthesis of collagen. Remarkably, the in vitro antifibrotic effects of CDDO were independent of PPAR-γ.ConclusionsThe PPAR-γ agonist triterpenoid CDDO attenuates fibrogenesis by antagonistically targeting canonical TGF-β/Smad and Akt signalling in a PPAR-γ-independent manner. These findings identify this synthetic triterpenoid as a potential new therapy for the control of fibrosis.